TX-ACELITY
Acelity announced today that its affiliate, KCI Holdings, Inc. (“KCI”), filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”), relating to a proposed initial public offering of KCI’s common stock. Prior to the effectiveness of the registration statement, there will be a restructuring as a result of which KCI will become the holding company of the businesses currently conducted by Acelity L.P. Inc. and its subsidiaries. The number of shares to be offered and the price range for the proposed offering have not yet been determined.
J.P. Morgan, Goldman Sachs & Co. LLC and BofA Merrill Lynch are acting as joint book-running managers for the proposed offering.
The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus related to the offering may be obtained from: J.P. Morgan, Attention: Prospectus Department c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, via telephone: 1-866-803-9204; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, via telephone: 1-866-471-2526 or by facsimile at 212-902-9316, or via email: prospectus-ny@ny.email.gs.com ; or BofA Merrill Lynch, Attn: Prospectus Department, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at dg.prospectus_requests@baml.com .
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Acelity
Acelity L.P. Inc. is a global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand. The KCI product portfolio is available in more than 90 countries. Headquartered in San Antonio, Texas, Acelity employs nearly 5,000 people around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190418005387/en/
Contact:
Maggie Fairchild Corporate Communications, Media Phone: +1-210-330-2666 Email: maggie.fairchild@acelity.com
David Clair, CFA Investor Relations Westwicke Partners Phone: +1-646-277-1266 Email: investors@acelity.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PUMA19.3.2024 10:01:32 CET | Press release
“Unfortunately, not a lot has changed for girls in football.”
MOOVE19.3.2024 09:02:26 CET | Press release
Moove secures USD $100 million Series B round
WI-CIELO19.3.2024 08:12:25 CET | Press release
Cielo Debuts First Generative AI for Talent Acquisition: CLO.ai
GALDERMA19.3.2024 07:01:34 CET | Press release
AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio
CA-NETAPP18.3.2024 23:01:28 CET | Press release
NetApp Empowers Customers to Securely “Talk to Their Data” in Collaboration with NVIDIA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom